• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Refinancing

Gyrus Capital's Essential Pharma refinances, inks two deals

  • Greg Gille
  • Greg Gille
  • @unquotenews
  • 22 December 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Essential Pharma, a UK pharmaceutical company backed by Gyrus Capital, has completed a refinancing providing capital to continue its organic and inorganic growth strategy.

Details remain undisclosed. The refinancing was an extension of the existing facilities, providing further firepower for acquisitions and allowing Gyrus to take a dividend recap, according to a source close to the situation.

In parallel with the refinancing, Essential Pharma completed two M&A deals in December.

It divested its 14-product portfolio, Essential Pharma Liquids Limited, to Rosemont Pharmaceuticals Limited. In conjunction with this divestiture, Essential Pharma also acquired Yorkdale Pharma Limited from Rosemont Pharmaceutical, adding five products to the Essential Pharma portfolio.

The company also expanded its global portfolio with product acquisitions for ocular and postpartum therapies from Novartis. Representing the worldwide rights (excluding US and India), these products are sold in more than 50 countries worldwide.

Gyrus Capital signed the acquisition of Essential Pharma in late 2019. The company was being acquired from its founding shareholders by the incumbent management, supported by a significant equity commitment from Gyrus's Cortex Fund, the deal-by-deal multi-asset vehicle that raised EUR 240m in 2019. Leverage was provided by Hayfin Capital Management.

Essential Pharma, based in Egham, Surrey, licences and sells speciality pharmaceuticals in the UK and European markets. According to its website, it specialises in "low-volume, difficult-to-manufacture but clinically well-established pharmaceutical products".

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Refinancing
  • UK / Ireland
  • Healthcare
  • Gyrus Capital
  • United Kingdom
  • Refinancing

More on Refinancing

The Unquote Podcast
Unquote Private Equity Podcast: The PE auction in times of exit scarcity

Rachel Lewis joins Harriet Matthews to discuss how auction process dynamics are changing against the current market backdrop

  • Industry
  • 23 January 2023
Banks and financial institutions
Alcentra takes keys to three PE-backed companies this year

Under Benefit Street Partners' ownership the alternative lender took over Lifetime, Optionis and Equiom

  • Refinancing
  • 16 December 2022
Catering for cruises and other marine vessels
Searchlight invests in Celestyal Cruises

Searchlight is investing in the cruise operator via its Searchlight Opportunities Fund

  • Refinancing
  • 29 November 2021
Fundraising in euros
Carlyle backs European strategies with ESG facility

Credit facility is linked to targets such as board diversity and greenhouse gas emissions monitoring

  • GPs
  • 07 September 2021

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013